Search clinical trials for: PL1

Total 1540 results

UCB Biopharma S.P.R.L.

Completed

A First-In-Human Study With a Single Dose UCB4019 in Healthy Volunteers

Healthy Volunteers

United Kingdom
Société des Produits Nestlé (SPN)

Completed

Effects of Specific Lipid Fractions-enriched Infant Formulae

Infant Growth

France, Italy
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Infusion of PD1/PDL1 Inhibitor Via Hepatic Arterial Versus Vein for Immunotherapy of Advanced Hepatocellular Carcinoma

Liver Cancer

China
Centre Hospitalier Universitaire de Besancon

Recruiting

Interest of Anti-telomerase T CD4 Immune Responses for Predicting the Effectiveness of Immunotherapies Targeting PD1 / PDL1 (ITHER)

Cancer

France
Coloplast A/S

Unknown

Investigating the Adhesion of New Adhesive to the Skin

Ileostomy - Stoma

Denmark
University Hospital, Angers

Completed

Exosomes Implication in PD1-PD-L1 Activation in OSAS (ExoSAS)

Cancer | Sleep Apnea Syndromes, Obstructive

France
Peking Union Medical College Hospital

Recruiting

Autologous HBV-specific T Cell Receptor Engineered T Cells (TCR-T) in Patients With HBV-related Advanced HCC

Hepatocellular Carcinoma

China
Universidade Estadual de Ponta Grossa
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

Completed

Effect of Increased Improve Time on Adhesive System (RCT)

Clinical Trial

Brazil
Universitätsklinikum Hamburg-Eppendorf

Terminated

Pretreatment of Patients Expecting Bariatric Surgery With the GLP-1 Analogon Liraglutid

Obesity

Germany
Movetis

Completed

Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP)

Chronic Intestinal Pseudo-Obstruction

United Kingdom
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

IT or IA Infusion of PD1/PDL1/CTLA4 Inhibitors Versus IV for Immunotherapy of Head/Neck Cancers (HNC)

Head/Neck Neoplasm

China
Istituto Clinico Humanitas

Completed

Comparing Two Types of Needle for Oocytes Retrieval (NEEDLE)

Infertility, Female | ART

Italy
Consorzio Oncotech
Quercegen Pharmaceuticals; Clinical Research Technology S.r.l.

Unknown

Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial (QUASAR)

Kidney Cancer | Renal Cell Carcinoma

Italy
Centre hospitalier de l'Université de Montréal...
Université de Montréal

Completed

Implementation and Evaluation of a Perceptual Learning Module on the Identification of the Brachial Plexus (MAP-IS)

Medical Education

Canada
Neurim Pharmaceuticals Ltd.

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Neu-P11 in Subjects With Primary Insomnia

Insomnia

France
Arbutus Biopharma Corporation

Completed

A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

Cancer | Neuroendocrine Tumors | Adrenocortical Carcinoma | ACC | NET

United States
M.D. Anderson Cancer Center

Withdrawn

PR1-Specific Cytotoxic T-Lymphocyte Infusion With Recurrent Chronic Myelogenous Leukemia (CML) After Allogeneic Hematopoietic Transplantation

Chronic Myelogenous Leukemia
Medtronic Cardiac Rhythm and Heart Failure

Suspended

Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction (FIRE-HFpEF)

Heart Failure With Preserved Ejection Fraction | Concentric Hypertrophy

United States
Lawson Health Research Institute

Completed

Effect of EPD on the Lumbar Acoustic Window at Term Pregnancy

Effects of; Anesthesia, Spinal and Epidural, in Pregnancy
Pluristem Ltd.

Completed

Safety and Efficacy of IM Injections of PLX-PAD for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty

Total Hip Arthroplasty | Muscle Injury

Germany
Hannah Choe
National Cancer Institute (NCI); Plexxikon

Completed

Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD

Acute Graft Versus Host Disease | Steroid Refractory Graft Versus Host Disease

United States
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Efficacy and Safety Evaluation of IBI308 in Treatment of Patients With Relapsed/Refractory Classical Hodgkin's Lymphoma (ORIENT-1)

Relapsed/Refractory Classical Hodgkin's Lymphoma

China
Innovent Biologics (Suzhou) Co. Ltd.

Terminated

Evaluation of Safety and Efficacy of IBI318 Monotherapy for Relapsed/Refractory Extranodal NK/T Cell Lymphoma (Nasal Type) Trial

Extranodal NK/T Cell Lymphoma, Nasal Type

China
Dilafor AB

Completed

Effect of Tafoxiparin on Cervical Ripening and Induction of Labor in Term Pregnant Women With an Unripe Cervix

Labor Onset and Length Abnormalities

Finland, Sweden
Mesoblast, Ltd.

Withdrawn

Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion

Degenerative Disc Disease | Spinal Stenosis | Degenerative Spondylolisthesis

United States
WideTrial, Inc.

Available

Expanded Access for Treatment Use of PLX-PAD in Critical Limb Ischemia (CLI)

Critical Limb Ischemia (CLI)
InxMed (Shanghai) Co., Ltd.

Recruiting

IN10018 in Combination With Standard Chemotherapy in High-grade Serous Epithelial Ovarian Cancer

Platinum-resistant Ovarian Cancer

China
Assiut University

Not yet recruiting

Assesment of JL1 Expression in Acute Leukemia

Acute Lymphoblastic Leukemia
W.L.Gore & Associates

Active, not recruiting

Evaluation of the GORE PV1 Device in Patients With Pulmonary Valve Dysfunction

Heart Defects, Congenital | Tetralogy of Fallot | Pulmonary Valve Insufficiency | Pulmonary Valve Stenosis

United States
Pluristem Ltd.

Terminated

Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19

COVID | ARDS

Israel, Germany
Pluristem Ltd.

Completed

Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation

Incomplete HCT (Hematopoietic Cell Transplantation)

United States, Israel
Dana-Farber Cancer Institute
CURE Foundation

Completed

Novel Social Media Intervention For Older Br CA Patients

Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III

United States
University Hospital of Split
University of Liverpool

Completed

Presenting Summary Information From Cochrane Systematic Reviews: Protocol for Research of Infographics Presentation vs. Plain Language Summary

Health Knowledge, Attitudes, Practice

Croatia
University of Split, School of Medicine

Completed

Comparison of Blogshot Formats With Standard Cochrane Plain Language Formats

Health Knowledge, Attitudes, Practice

Croatia
Pluristem Ltd.

Completed

Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)

Peripheral Vascular Disease | Peripheral Artery Disease | Critical Limb Ischemia

United States
Medytox Korea

Completed

Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar Lines

Glabellar Frown Lines

Korea, Republic of
Bioray Laboratories
The First Affiliated Hospital of Zhengzhou University

Not yet recruiting

Efficacy and Safety Evaluation of PD1-BCMA-CART

Multiple Myeloma

China
Pliant Therapeutics, Inc.

Completed

Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States, Belgium, Australia, Netherlands, Canada, Italy, New Zealand
Interventional Spine, Inc.

Withdrawn

A Post-Market Study of Transfacet Lumbar Spine Fixation and Fusion Utilizing the PERPOS™ PLS System

Lumbar Facet Disease
Lyndra Inc.

Completed

Study to Evaluate Safety/Duration in Stomach of Extended Release Capsules in Healthy Adults

Healthy | Gastric Retention

Australia
Dilafor AB

Completed

Effect of Tafoxiparin to Treat Primary Slow Progress of Labor Including Prolonged Latent Phase and Labor Arrest

Labor, Obstetric

Finland, Sweden, Denmark
Pliant Therapeutics, Inc.

Recruiting

Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis

United States, Australia, Taiwan, Korea, Republic of, New Zealand, Canada, Chile, Israel
Pliant Therapeutics, Inc.

Terminated

Evaluation of the Safety, Tolerability, and Pharmacokinetics of PLN-74809 in Participants With Acute Respiratory Distress Syndrome (ARDS) Associated With at Least Severe COVID-19

Acute Respiratory Distress Syndrome | SARS-CoV-2

United States
Huashan Hospital
Shanghai Cell Therapy Research Institute

Active, not recruiting

Adoptive Cell Therapy of Autologous TIL and PD1-TIL Cells for Patients With Glioblastoma Multiforme

Glioblastoma Multiforme

China
Sheba Medical Center

Terminated

Detection of Meconium in Amniotic Fluid in Post Term Pregnancies

Meconium

Israel
Pliant Therapeutics, Inc.

Completed

Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809) (PLN-74809)

Idiopathic Pulmonary Fibrosis

United States
Neuromod Devices Ltd.
University Hospital Regensburg

Completed

Treatment Evaluation of Neuromodulation for Tinnitus (TENT-A)

Tinnitus

Germany, Ireland
Pluristem Ltd.

Unknown

Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization

Critical Limb Ischemia (CLI)

Germany, United Kingdom, Hungary, United States, Bulgaria, Czechia, Israel, North Macedonia, Poland
Northern California Institute of Research and Education
UCB Pharma; University of California, San Francisco; San Francisco Veterans Affairs... and other collaborators

Unknown

Policy on Optimal Epilepsy Management (POEM)

Epilepsy | Seizure Disorder

United States
Pluristem Ltd.

Completed

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Intermittent Claudication | Peripheral Artery Disease

United States, Germany, Korea, Republic of, Israel

Search clinical trials for: PL1

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Italy

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations